Search
Patexia Research
Case number 1:19-cv-00164

Genentech, Inc. et al v. Granules Pharmaceuticals, Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jul 9, 2020 1 Complaint (17)
Jul 15, 2019 18 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 8,778,947 B2. (Attachments: # (1) Order)(nms)
Jul 15, 2019 18 Order (5)
Jul 15, 2019 18 Patent/Trademark Report to Commissioner (1)
Jul 12, 2019 17 Order (5)
Docket Text: SO ORDERED Granting [16] Stipulation and Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/12/2019. (nms)
Jul 12, 2019 16 Stipulation of Dismissal (5)
Docket Text: STIPULATION and Proposed Order of Dismissal, by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc.. (Ormerod, Eve) Modified on 7/12/2019 (nms).
May 16, 2019 N/A Oral Order (0)
Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
May 14, 2019 14 Answer to Counterclaim (17)
Docket Text: ANSWER to [12] Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Blumenfeld, Jack) Modified on 5/15/2019 (nms).
Apr 23, 2019 13 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Granules India Ltd. for Granules Pharmaceuticals, Inc., Granules Pharmaceuticals, Inc., Granules USA, Inc., Granules USA, Inc. filed by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc.. (Belgam, Neal)
Apr 23, 2019 12 Answer to Complaint (27)
Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against All Plaintiffs, by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc..(Ormerod, Eve) Modified on 4/24/2019 (nms).
Mar 28, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Chidambaram S. Iyer and Michael R. Dzwonczyk for Granules India Ltd., Granules Pharmaceuticals, Inc., and Granules USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
Mar 26, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Chidambaram S. Iyer and Michael R. Dzwonczyk, filed by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc.. Signed by Judge Richard G. Andrews on 3/26/2019. (nms)
Mar 25, 2019 11 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Chidambaram S. Iyer and Michael R. Dzwonczyk - filed by Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc.. (Ormerod, Eve)
Mar 8, 2019 N/A Add Attorneys Pro Hac Vice (0)
Feb 12, 2019 N/A SO ORDERED (0)
Feb 11, 2019 10 Motion for Leave to Appear Pro Hac Vice (15)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen)
Feb 7, 2019 N/A SO ORDERED (0)
Feb 7, 2019 9 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwisse respond to the Complaint to April 26, 2019 - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen)
Feb 6, 2019 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Granules India Ltd. served on 2/5/2019, answer due 2/26/2019. (Jacobs, Karen)
Jan 31, 2019 7 Declaration (9)
Docket Text: DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 2/1/2019 (nms).
Jan 30, 2019 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Granules USA, Inc. served on 1/29/2019, answer due 2/19/2019. (Blumenfeld, Jack)
Jan 30, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00120-RGA, 1:19-cv-00123-RGA, 1:19-cv-00130-RGA through 1:19-cv-00132-RGA, 1:19-cv-00136-RGA, 1:19-cv-00141-RGA, 1:19-cv-00142-RGA, 1:19-cv-00154-RGA and 1:19-cv-00164-RGA (rjb)
Jan 29, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Granules India Ltd. on 1/29/2019; Granules Pharmaceuticals, Inc. on 1/29/2019; Granules USA, Inc. on 1/29/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)
Jan 28, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Genentech, Inc. for InterMune, Inc.; Other Affiliate Roche Holding Ltd., Other Affiliate Novartis Ltd., Other Affiliate Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc.. (nmg)
Jan 28, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 8,778,947 B2. (nmg)
Jan 28, 2019 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/20/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/15/2022. (nmg)
Jan 28, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Jan 28, 2019 1 Civil Cover Sheet (2)
Jan 28, 2019 1 Main Document (17)
Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Granules India Ltd., Granules Pharmaceuticals, Inc., Granules USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2554841.) - filed by InterMune, Inc., Genentech, Inc.. (Attachments: # (1) Exhibit 1-3, # (2) Civil Cover Sheet)(nmg)
Jan 28, 2019 1 Exhibit 1-3 (57)
Jan 28, 2019 1 Complaint* (1)
Menu